KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Emergent BioSolutions (EBS) Receivables Refunds (2016 - 2020)

Historic Receivables Refunds for Emergent BioSolutions (EBS) over the last 12 years, with Q1 2020 value amounting to $10.2 million.

  • Emergent BioSolutions' Receivables Refunds changed N/A to $10.2 million in Q1 2020 from the same period last year, while for Mar 2020 it was $10.2 million, marking a year-over-year change of. This contributed to the annual value of $4.6 million for FY2019, which is 4651.16% down from last year.
  • As of Q1 2020, Emergent BioSolutions' Receivables Refunds stood at $10.2 million.
  • Over the past 5 years, Emergent BioSolutions' Receivables Refunds peaked at $11.8 million during Q3 2016, and registered a low of $2.4 million during Q4 2017.
  • Over the past 5 years, Emergent BioSolutions' median Receivables Refunds value was $7.0 million (recorded in 2018), while the average stood at $7.3 million.
  • As far as peak fluctuations go, Emergent BioSolutions' Receivables Refunds tumbled by 7784.76% in 2016, and later surged by 25833.33% in 2018.
  • Over the past 5 years, Emergent BioSolutions' Receivables Refunds (Quarter) stood at $10.0 million in 2016, then crashed by 75.99% to $2.4 million in 2017, then skyrocketed by 258.33% to $8.6 million in 2018, then plummeted by 46.51% to $4.6 million in 2019, then skyrocketed by 121.74% to $10.2 million in 2020.
  • Its Receivables Refunds was $10.2 million in Q1 2020, compared to $4.6 million in Q4 2019 and $8.6 million in Q4 2018.